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Abstract 
Background: Whether post-anticoagulation D-dimer levels are useful in predicting 
recurrence in elderly patients with unprovoked venous thromboembolism is unknown. 
Methods: We followed-up 157 patients aged ≥65 years with acute symptomatic 
unprovoked venous thromboembolism in a prospective multicenter cohort study. All 
patients completed 3-12 months of anticoagulation and then underwent quantitative 
D-dimer testing (ELISA, VIDAS DD) 12 months after the index venous 
thromboembolism. The outcome was recurrent symptomatic venous 
thromboembolism after D-dimer measurement. We examined associations between 
log-transformed and dichotomized D-dimer values and the time to venous 
thromboembolism recurrence using competing risk regression, adjusting for age, sex 
and overt pulmonary embolism. 
Results: There was no statistically significant association between quantitative or 
dichotomized D-dimer levels and venous thromboembolism recurrence. The area 
under the receiver operating characteristic curve for predicting recurrent venous 
thromboembolism was moderate (0.66, 95% confidence interval [CI] 0.51-0.82). The 
negative likelihood ratios were 0.34 (95% CI 0.05-2.38) at the usual and 0.34 (95% 
CI 0.09-1.29) at the age-adjusted cutoff values. Among patients with normal D-dimer 
results, venous thromboembolism recurrence rates were 6.8 (95% CI 2.2-21.2) per 
100 patient-years using the usual and 7.1 (95% CI 3.2-15.8) per 100 patient-years 
using the age-adjusted cutoff values. 
Conclusion: D-dimer testing alone may not be useful in identifying elderly patients 
with unprovoked venous thromboembolism who are at low risk of recurrent venous 
thromboembolism and in whom anticoagulants may be safely stopped. 
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Background 
Current guidelines recommend extended anticoagulation in patients with a first 
unprovoked venous thromboembolism if the bleeding risk is not high.1 However, in 
10-34% of these patients the recurrence risk is so low that extended anticoagulation 
beyond three months may not be necessary.2,3 The measurement of D-dimer levels, 
alone or in combination with clinical factors, has received much attention as a tool to 
identify low-risk patients.2-4 Normal D-dimer levels performed after discontinuation of 
anticoagulation have a high negative predictive value for recurrent venous 
thromboembolism,2 and thus, D-dimer testing may help to guide the duration of 
anticoagulation.5 
D-dimer levels rise with increasing age and in some,3 albeit not all studies,4 
increasing age was associated with a higher risk of recurrent venous 
thromboembolism. To our knowledge, no study has specifically examined the 
association between post-anticoagulation D-dimer levels and venous 
thromboembolism recurrence in elderly patients. We aimed to evaluate the 
usefulness of post-anticoagulation D-dimer levels in predicting venous 
thromboembolism recurrence in elderly patients with unprovoked venous 
thromboembolism. 
 
Methods 
This study was performed as part of a prospective multicenter cohort study to 
assess medical outcomes in elderly patients with acute symptomatic venous 
thromboembolism from nine Swiss university and non-university hospitals (09/2009-
12/2013).6 A detailed description of the study methods has been published 
previously.6 Briefly, consenting consecutive patients aged ≥65 years with objectively 
diagnosed, symptomatic deep vein thrombosis or pulmonary embolism were 
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prospectively identified and followed over time. The ethics committee at each 
participating center approved the study. For the sake of this analysis, only patients 
with unprovoked venous thromboembolism, defined as venous thromboembolism in 
the absence of immobilization, major surgery, oral estrogen therapy, or active cancer 
during the last 3 months, who had completed a 3 to 12-month course of 
anticoagulation were included. 
In all patients a blood sample was taken 12 months after index venous 
thromboembolism. Samples were immediately centrifuged, frozen, and stored at  
-80°C and sent for analyses to a central study labo ratory. D-dimer was determined by 
ELISA (VIDAS, bioMérieux). Normal D-dimer was defined according to the cutoff 
value recommended by the manufacturer (normal <500 ng/ml). In addition, given that 
all patients were aged ≥65 years in our cohort, we also calculated age-adjusted cutoff 
values (patient’s age multiplied by 10) to take into account higher D-dimer levels in 
the elderly.7 
The outcome was the recurrence of symptomatic, objectively confirmed venous 
thromboembolism after D-dimer measurement, defined as symptomatic new deep 
vein thrombosis or pulmonary embolism based on predefined imaging criteria or 
autopsy, as previously described.6 Three blinded, independent experts adjudicated 
all recurrences. 
We compared baseline characteristics between patients with normal and 
abnormal D-dimer values using the chi-squared test and the non-parametric 
Wilcoxon rank-sum test as appropriate. We examined associations between log-
transformed and dichotomized D-dimer values and the time to a first venous 
thromboembolism recurrence using competing risk regression according to Fine and 
Gray,8 accounting for non-pulmonary-embolism-related death as a competing event. 
Adjustment was done for age, sex, and overt pulmonary embolism. We estimated 
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sensitivity, specificity, positive and negative predictive values and likelihood ratios for 
abnormal versus normal D-dimer levels. We assessed the discriminative power of D-
dimer values for predicting recurrent venous thromboembolism by calculating the 
area under the receiver operating characteristic (ROC) curve. Our primary analysis 
included all patients with unprovoked venous thromboembolism. In a first sensitivity 
analysis, we included patients with a first venous thromboembolism event only. In a 
second sensitivity analysis, we also included patients without D-dimer measurement 
at 12 months by imputing the median D-dimer value of all patients with a value <500 
ng/ml and the median D-dimer value of all patients with a value of ≥500 ng/ml. We 
considered P values <0.05 to be statistically significant. All analyses were done using 
Stata 13 (Stata Corporation, College Station, Texas). 
 
Results 
Of the 225 patients with unprovoked venous thromboembolism who 
successfully completed a 3 to 12-month course of anticoagulation and survived the 
first 12 months initially enrolled in our cohort, we excluded 36 without D-dimer 
measurement, and 32 who withdrew consent or denied data use within the first year. 
Our final study sample comprised 157 patients with acute unprovoked venous 
thromboembolism. 
The median age was 74 years (interquartile range [IQR] 69-80 years) (Table 
1). Median follow-up was 23.9 months (IQR 17.4-29.5 months). Overall, 20% 
(31/157) of patients had recurrent venous thromboembolism during follow-up. 
There was no statistically significant association between quantitative D-dimer 
levels (adjusted sub-hazard ratio [SHR] per log-unit increase 1.78, 95% confidence 
interval [CI] 0.95-3.36, P=0.07), or dichotomized D-dimer levels and venous 
thromboembolism recurrence (adjusted SHR for ≥500 ng/ml versus <500 ng/ml 1.86, 
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95% CI 0.57-6.03, P=0.3; adjusted SHR for age-adjusted D-dimer cutoff levels 1.76, 
95% CI 0.7-4.42, P=0.23). Among patients with normal D-dimer results, venous 
thromboembolism recurrence rates were 6.8 (95% CI 2.2-21.2) per 100 patient-years 
using the test’s usual and 7.1 (95% CI 3.2-15.8) per 100 patient-years using the age-
adjusted cutoff. Among patients with abnormal D-dimer results, venous 
thromboembolism recurrence rates were 12.7 (95% CI 8.8-18.4) per 100 patient-
years using test’s usual and 13.9 (95% CI 9.4-20.6) per 100 patient-years using the 
age-adjusted cutoff. 
The area under the ROC curve for predicting venous thromboembolism 
recurrence at 12 months was moderate (0.66, 95% CI 0.51-0.82). At both cutoff 
values, D-dimer showed relatively modest positive and negative likelihood ratios 
(Table 2). The exclusion of patients with prior venous thromboembolism (n=23) in a 
sensitivity analysis did not significantly change the results (data not shown). When 
we imputed the 36 missing D-dimer values as normal (379 ng/ml, median value of 
patients with a D-dimer <500 ng/ml) or abnormal (1154 ng/ml, median value of 
patients with a D-dimer ≥500 ng/ml) in another sensitivity analysis, the area under the 
ROC curve for predicting recurrent venous thromboembolism at 12 months was 0.59 
(95% CI 0.44-0.73) and 0.63 (95% CI 0.50-0.76), respectively. 
 
Discussion 
In our prospective cohort, post-anticoagulation D-dimer levels were not 
statistically significantly associated with venous thromboembolism recurrence in 
elderly patients with unprovoked venous thromboembolism. In contrast to previously 
published studies that demonstrated an association between D-dimer levels and 
venous thromboembolism recurrence, patients in our study were substantially older, 
and to our knowledge, no prior study focused exclusively on elderly patients. Even 
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though our study might be underpowered to detect a significant association between 
D-dimer levels and venous thromboembolism recurrence, the risk for recurrent 
venous thromboembolism in patients who had normal D-dimer results was 6.8-7.1 
per 100 patient-years, which is considered not low enough to justify stopping 
anticoagulation in these patients. Furthermore, the negative likelihood ratios at the 
test’s usual and at the age-adjusted cutoff values as well as the discriminative power 
of D-dimer for predicting recurrent venous thromboembolism were only moderate. 
Thus, D-dimer testing alone may not suffice to identify elderly patients with 
unprovoked venous thromboembolism who are at low risk of venous 
thromboembolism recurrence. 
Our study has potential limitations. First, we excluded 36 patients because 
they had no D-dimer measurement. When we imputed the 36 missing D-dimer values 
as normal or abnormal in sensitivity analyses, the area under the ROC curve for 
predicting recurrent venous thromboembolism remained similar, confirming the 
robustness of our results. Second, because our cohort included elderly patients only, 
our results do not apply to younger patients. Third, while we determined D-dimer 
levels at a fixed point in time (12 months after the index venous thromboembolism) in 
our study, previous studies showing an association between D-dimer and venous 
thromboembolism recurrence measured D-dimer mainly within 3-5 weeks after 
discontinuation of anticoagulation. However, the timing of D-dimer measurement 
appeared to have no effect on prediction of venous thromboembolism recurrence in 
previous studies.9 Finally, our study used a specific D-dimer test (ELISA VIDAS) and 
therefore our results may not be necessarily applicable to other D-dimer tests. 
In conclusion, D-dimer testing alone may not be useful in identifying elderly 
patients with unprovoked venous thromboembolism who are at low risk of recurrent 
venous thromboembolism and in whom anticoagulants may be safely stopped. 
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Table 1. Patient baseline characteristics by D-dimer level 
 All 
(N=157) 
D-dimer  
≥500 ng/ml 
(N=132) 
D-dimer  
<500 ng/ml 
(N=25) 
P-
value 
 n (%) or median (interquartile range) 
 
Age (years)* 74.0 (69.0; 80.0) 75.0 (70.0; 80.8) 69.0 (67.0; 74.0) <0.01 
Female sex 65 (41) 57 (43) 8 (32) 0.30 
VTE location 
PE 
Proximal DVT 
Distal DVT 
 
93 (59) 
45 (29) 
19 (12) 
 
77 (58) 
41 (31) 
14 (11) 
 
16 (64) 
4 (16) 
5 (20) 
0.19 
BMI (kg/m2)* 27.5 (24.8; 30.5) 27.6 (24.8; 30.5) 26.3 (24.6; 30.1) 0.38 
Prior VTE 23 (15) 20 (15) 3 (12) 0.68 
Duration of prior 
AC (months) 
6.3 (5.3; 7.1) 6.3 (5.0; 7.1) 6.7 (5.7; 7.5) 0.14 
VTE = venous thromboembolism; PE = pulmonary embolism; DVT = deep vein thrombosis;  
BMI = body mass index; AC = anticoagulation. 
*At the time of the index VTE.  
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Table 2. Performance of D-dimer for predicting recurrent venous 
thromboembolism at 12 months 
Cutoff Sensitivity, 
% (95% CI) 
Specificity, 
% (95% CI) 
PPV, % 
(95% CI) 
NPV, % 
(95% CI) 
Positive LHR 
(95% CI) 
Negative LHR 
(95% CI) 
500 ng/ml 94.1 (73.0; 
99.0) 
17.1 (11.8; 
24.2) 
12.1 (7.6; 
18.8) 
96.0 (80.5; 
99.3) 
1.14 (0.99; 
1.31) 
0.34 (0.05; 
2.38) 
Age-adjusted* 88.2 (65.7; 
96.7) 
34.3 (26.9; 
42.5) 
14.0 (8.7; 
21.8) 
96.0 (86.5; 
98.9) 
1.34 (1.09; 
1.66) 
0.34 (0.09; 
1.29) 
VTE = venous thromboembolism; CI = confidence interval; PPV = positive predictive value;  
NPV = negative predictive value; LHR = likelihood ratio. 
*Defined as the patient’s age multiplied by 10. 
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Clinical significance 
• D-dimer levels were not significantly associated with recurrent venous 
thromboembolism in the elderly with unprovoked venous 
thromboembolism. 
• The negative likelihood ratio (0.34) and the discriminative power (0.66) of 
post-anticoagulation D-dimer for predicting recurrence in elderly patients 
with unprovoked venous thromboembolism were only moderate. 
• Post-anticoagulation D-dimer testing alone was not useful in identifying 
elderly patients with unprovoked venous thromboembolism who are at low 
risk of recurrence. 
